Mylan Selected As Supplier Of ARV Medications By South African Government

(RTTNews) - Mylan Inc. (MYL) announced that its subsidiary in India, Mylan Laboratories Ltd., a manufacturer of antiretroviral (ARV) drugs, has been selected, through its South African-based subsidiary Mylan (Proprietary) Limited, as one of the suppliers of ARV medications to the South African National Department of Health for the tender period April 1, 2015 to March 31, 2018. As a part of the award, Mylan will supply the South African Government with triple therapy fixed dose combination (FDC) treatments.

In 2012, Mylan entered the South African market with a comprehensive portfolio of ARV medications, consisting of first- and second-line adult and pediatric therapies, including several dual and triple FDCs. Mylan was previously selected as a supplier for the 2013/2014 tender. The company supplies ARV drugs to more than 100 countries around the world.